Tag: FDA Orange Book

By Harriet Calvington
0 Comments

Authorized Generics vs. Brand Names: Are They Truly Therapeutically Equivalent?

Explore whether authorized generics are therapeutically equivalent to brand-name drugs. Learn about the FDA regulations, the difference between NDA and ANDA approvals, and how authorized generics compare to typical generics in cost and efficacy.

7 Feb

By Harriet Calvington
15 Comments

FDA Orange Book: Where to Find Patent Expiration Dates for Generic Drugs

The FDA Orange Book is the official source for patent expiration dates of brand-name drugs in the U.S. Learn how to find and interpret these dates to predict when generic versions will become available.

Compare Iverjohn (Ivermectin) with Alternatives for Parasite Treatment

Quality Assurance Units: Why Independent Oversight Is Non-Negotiable in Production

PCOS and Infertility: How Polycystic Ovary Syndrome Affects Fertility

Metabolic Rate: Understanding Adaptive Thermogenesis and Reverse Dieting

Common Manufacturing Defects in Generic Drugs and How They Impact Safety